These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role of oxidized low-density lipoprotein in the atherosclerosis of uremia. Drüeke TB; Nguyen Khoa T; Massy ZA; Witko-Sarsat V; Lacour B; Descamps-Latscha B Kidney Int Suppl; 2001 Feb; 78():S114-9. PubMed ID: 11168995 [TBL] [Abstract][Full Text] [Related]
5. Carbonyl stress in chronic renal failure: the effect of haemodialysis. Dursun E; Dursun B; Süleymanlar G; Ozben T Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036 [TBL] [Abstract][Full Text] [Related]
6. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Stenvinkel P Blood Purif; 2001; 19(2):143-51. PubMed ID: 11150801 [No Abstract] [Full Text] [Related]
7. Protein thiol oxidation and lipid peroxidation in patients with uraemia. Prakash M; Upadhya S; Prabhu R Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466 [TBL] [Abstract][Full Text] [Related]
8. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Witko-Sarsat V; Friedlander M; Capeillère-Blandin C; Nguyen-Khoa T; Nguyen AT; Zingraff J; Jungers P; Descamps-Latscha B Kidney Int; 1996 May; 49(5):1304-13. PubMed ID: 8731095 [TBL] [Abstract][Full Text] [Related]
9. Increased whole blood chemiluminescence in patients with chronic renal failure independent of hemodialysis treatment. Rysz J; Potargowicz E; Banach M; Luczyńska M; Stolarek R; Białasiewicz P; Kasielski M; Ciałkowska-Rysz A; Nowak D Arch Immunol Ther Exp (Warsz); 2006; 54(5):347-55. PubMed ID: 17031465 [TBL] [Abstract][Full Text] [Related]
10. Lipid metabolism in dialysis patients-the story gets more complicated. Ponda MP; Barash I Semin Dial; 2008; 21(5):390-4. PubMed ID: 18764791 [TBL] [Abstract][Full Text] [Related]
11. Oxidatively-modified and glycated proteins as candidate pro-inflammatory toxins in uremia and dialysis patients. Piroddi M; Depunzio I; Calabrese V; Mancuso C; Aisa CM; Binaglia L; Minelli A; Butterfield AD; Galli F Amino Acids; 2007; 32(4):573-92. PubMed ID: 17356806 [TBL] [Abstract][Full Text] [Related]
12. Disorders of carbohydrate and lipid metabolism in uremia. Bagdade Nephron; 1975; 14(2):153-62. PubMed ID: 1093054 [TBL] [Abstract][Full Text] [Related]
13. New insights about uremia through its attenuation by dialysis. Maher JF Artif Organs; 1986 Aug; 10(4):306-12. PubMed ID: 3753257 [No Abstract] [Full Text] [Related]
14. Flow cytometric assays of oxidative burst activity in phagocytes. Rothe G; Valet G Methods Enzymol; 1994; 233():539-48. PubMed ID: 8015489 [No Abstract] [Full Text] [Related]
15. Protein damage and inflammation in uraemia and dialysis patients. Galli F Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v20-36. PubMed ID: 17586842 [TBL] [Abstract][Full Text] [Related]
16. Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Pupim LB; Himmelfarb J; McMonagle E; Shyr Y; Ikizler TA Kidney Int; 2004 Jun; 65(6):2371-9. PubMed ID: 15149350 [TBL] [Abstract][Full Text] [Related]
17. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Himmelfarb J; Stenvinkel P; Ikizler TA; Hakim RM Kidney Int; 2002 Nov; 62(5):1524-38. PubMed ID: 12371953 [TBL] [Abstract][Full Text] [Related]
18. Vitamin C and cellular immune functions. Protection against hypochlorous acid-mediated inactivation of glyceraldehyde-3-phosphate dehydrogenase and ATP generation in human leukocytes as a possible mechanism of ascorbate-mediated immunostimulation. Anderson R; Smit MJ; Joone GK; Van Staden AM Ann N Y Acad Sci; 1990; 587():34-48. PubMed ID: 2163229 [No Abstract] [Full Text] [Related]